- Home
- DV vs CNTA Comparison
DV vs CNTA Comparison
Compare DV & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DV
- CNTA
- Stock Information
- Founded
- DV 2008
- CNTA 2020
- Country
- DV United States
- CNTA United Kingdom
- Employees
- DV N/A
- CNTA N/A
- Industry
- DV Computer Software: Prepackaged Software
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- DV Technology
- CNTA Health Care
- Exchange
- DV Nasdaq
- CNTA Nasdaq
- Market Cap
- DV 2.2B
- CNTA 1.8B
- IPO Year
- DV 2021
- CNTA 2021
- Fundamental
- Price
- DV $13.34
- CNTA $12.30
- Analyst Decision
- DV Buy
- CNTA Strong Buy
- Analyst Count
- DV 18
- CNTA 10
- Target Price
- DV $19.08
- CNTA $26.11
- AVG Volume (30 Days)
- DV 2.3M
- CNTA 617.5K
- Earning Date
- DV 05-08-2025
- CNTA 05-20-2025
- Dividend Yield
- DV N/A
- CNTA N/A
- EPS Growth
- DV N/A
- CNTA N/A
- EPS
- DV 0.29
- CNTA N/A
- Revenue
- DV $681,128,000.00
- CNTA N/A
- Revenue This Year
- DV $13.06
- CNTA N/A
- Revenue Next Year
- DV $12.77
- CNTA N/A
- P/E Ratio
- DV $45.55
- CNTA N/A
- Revenue Growth
- DV 15.30
- CNTA N/A
- 52 Week Low
- DV $11.52
- CNTA $7.75
- 52 Week High
- DV $23.11
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- DV 48.38
- CNTA 40.97
- Support Level
- DV $13.16
- CNTA $11.88
- Resistance Level
- DV $13.63
- CNTA $14.39
- Average True Range (ATR)
- DV 0.44
- CNTA 0.79
- MACD
- DV 0.19
- CNTA -0.00
- Stochastic Oscillator
- DV 52.15
- CNTA 18.68
About DV DoubleVerify Holdings Inc.
DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.